Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Cash Flow Reinvestment Rate
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Cash Flow Reinvestment Rate of 0.39x as of December 2025, reinvesting CN¥711.93 Million (capex CN¥330.65 Million plus investments CN¥381.27 Million) from operating cash flow of CN¥1.84 Billion. Check 600332 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Cash Flow Reinvestment Rate (2000–2025)
Historical reinvestment intensity for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd across 24 annual periods. Explore Guangzhou Baiyunshan Pharmaceutical Hold long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Year-by-year capital reinvestment analysis for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. For live market cap and broader valuation context, see Guangzhou Baiyunshan Pharmaceutical Hold stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 12.98x | CN¥3.38 Billion | CN¥260.23 Million | CN¥1.24 Billion | ▲ +649.2% |
| 2024 | 1.73x | CN¥5.96 Billion | CN¥3.44 Billion | CN¥1.13 Billion | ▲ +49.9% |
| 2023 | 1.16x | CN¥4.74 Billion | CN¥4.10 Billion | CN¥1.63 Billion | ▲ +6.2% |
| 2022 | 1.09x | CN¥7.62 Billion | CN¥7.00 Billion | CN¥1.38 Billion | ▲ +375.8% |
| 2021 | 0.23x | CN¥1.30 Billion | CN¥5.67 Billion | CN¥1.25 Billion | ▼ -90.3% |
| 2020 | 2.37x | CN¥1.39 Billion | CN¥585.19 Million | CN¥876.50 Million | ▲ +227.5% |
| 2019 | 0.72x | CN¥3.63 Billion | CN¥5.02 Billion | CN¥2.40 Billion | ▲ +314.7% |
| 2018 | 0.17x | CN¥909.71 Million | CN¥5.22 Billion | CN¥478.62 Million | ▼ -87.5% |
| 2017 | 1.40x | CN¥2.57 Billion | CN¥1.83 Billion | CN¥196.77 Million | ▲ +617.1% |
| 2016 | 0.20x | CN¥477.18 Million | CN¥2.44 Billion | CN¥228.03 Million | ▼ -52.6% |
| 2015 | 0.41x | CN¥800.01 Million | CN¥1.94 Billion | CN¥515.34 Million | ▲ +105.2% |
| 2014 | 0.20x | CN¥353.65 Million | CN¥1.76 Billion | CN¥353.65 Million | ▼ -23.3% |
| 2013 | 0.26x | CN¥350.35 Million | CN¥1.34 Billion | CN¥350.35 Million | ▲ +151.9% |
| 2012 | 0.10x | CN¥52.61 Million | CN¥506.53 Million | CN¥52.61 Million | ▼ -90.9% |
| 2010 | 1.14x | CN¥83.20 Million | CN¥73.17 Million | CN¥83.20 Million | ▲ +470.6% |
| 2009 | 0.20x | CN¥87.56 Million | CN¥439.39 Million | CN¥87.56 Million | ▼ -99.0% |
| 2008 | 20.80x | CN¥126.98 Million | CN¥6.10 Million | CN¥126.98 Million | ▲ +6271.7% |
| 2007 | 0.33x | CN¥122.69 Million | CN¥375.74 Million | CN¥122.69 Million | ▼ -86.0% |
| 2006 | 2.33x | CN¥90.45 Million | CN¥38.88 Million | CN¥90.45 Million | ▲ +173.7% |
| 2005 | 0.85x | CN¥124.36 Million | CN¥146.32 Million | CN¥124.36 Million | ▼ -44.8% |
| 2004 | 1.54x | CN¥308.69 Million | CN¥200.54 Million | CN¥308.69 Million | ▲ +49.8% |
| 2002 | 1.03x | CN¥173.70 Million | CN¥169.01 Million | CN¥173.70 Million | ▼ -10.2% |
| 2001 | 1.14x | CN¥160.44 Million | CN¥140.15 Million | CN¥160.44 Million | ▲ +100.9% |
| 2000 | 0.57x | CN¥163.53 Million | CN¥286.95 Million | CN¥163.53 Million | — |